Taiwan Semiconductor
TSM
Adobe
ADBE
Apple
AAPL
4
Cisco
CSCO
5
Qualcomm
QCOM
US Stock MarketDetailed Quotes
LRMR Larimar Therapeutics
- 2.801
- +0.411+17.19%
Trading Apr 30 13:44 ET
179.34MMarket Cap-2.12P/E (TTM)
2.920High2.400Low2.00MVolume2.400Open2.390Pre Close5.33MTurnover7.31%Turnover RatioLossP/E (Static)64.03MShares11.20052wk High1.04P/B76.84MFloat Cap1.61052wk Low--Dividend TTM27.43MShs Float664.320Historical High--Div YieldTTM21.76%Amplitude1.530Historical Low2.660Avg Price1Lot Size
Larimar Therapeutics Stock Forum
Sign in to post a comment
$Larimar Therapeutics (LRMR.US)$ what a joke
1
1
$Larimar Therapeutics (LRMR.US)$
Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich's Ataxia
Thursday, 23rd January at 4:05 pm
• Adolescents receive a weight-based dose equivalent to the 50 mg adult dose
• Adolescents 12-17 years old who complete participation in the pharmacokinetic (PK) run-in study will be eligible to screen in the ongoing open label extension (OLE) study
• Larimar is continuing to enrol...
Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich's Ataxia
Thursday, 23rd January at 4:05 pm
• Adolescents receive a weight-based dose equivalent to the 50 mg adult dose
• Adolescents 12-17 years old who complete participation in the pharmacokinetic (PK) run-in study will be eligible to screen in the ongoing open label extension (OLE) study
• Larimar is continuing to enrol...
$Larimar Therapeutics (LRMR.US)$ why this s*** went down despite positive data?
1
$Larimar Therapeutics (LRMR.US)$
Larimar Therapeutics Announces Positive Initial Data from Ongoing Long-term Open Label Extension Study & Progress Across Nomlabofusp Program for Friedreich's Ataxia
Monday, 16th December at 7:00 am
• Daily subcutaneous injections of 25 mg nomlabofusp in 14 participants were generally well tolerated for up to 260 days in the ongoing open label extension (OLE) study
• Tissue frataxin (FXN) levels showed mean change from baseline of 1.32 pg/μg in buccal cells a...
Larimar Therapeutics Announces Positive Initial Data from Ongoing Long-term Open Label Extension Study & Progress Across Nomlabofusp Program for Friedreich's Ataxia
Monday, 16th December at 7:00 am
• Daily subcutaneous injections of 25 mg nomlabofusp in 14 participants were generally well tolerated for up to 260 days in the ongoing open label extension (OLE) study
• Tissue frataxin (FXN) levels showed mean change from baseline of 1.32 pg/μg in buccal cells a...
No comment yet
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
felixfella OP : couldn't go up if it was riding on a airplane...